New Delhi: Drug maker Glenmark Pharmaceuticals Ltd said on Wednesday it will stop selling its morphine sulfate drug in the US, complying with a warning by that country’s drugs regulator. “In compliance with the conditions of the warning letter, Glenmark will cease distribution of their morphine sulfate product line within the timelines indicated by the FDA,” the company said in a statement.